Category: Johnson & Johnson

Johnson & Johnson’s dengue antiviral drug shows positive results

Novel anti-viral drug developed by Johnson & Johnson (J&J) arm Janssen Pharmaceutical provides “strong protection” against dengue in non-human primates and mice, early stage clinical data published in ‘Nature’ journal has revealed. “The first-in-class antiviral, which was shown to be safe and…

Continue Reading Johnson & Johnson’s dengue antiviral drug shows positive results

Latest Innovations, Drivers and Industry Key Events 2021-2027 I Top key players-Recursion Pharmaceuticals, Inc, IntraBio Inc, Johnson & Johnson Services,& Others. – The Manomet Current

“The global Tay-Sachs Disease Market was worth USD billion in 2019 and is expected to grow to USD billion by 2027, with a CAGR of %. from 2020 to 2027. Over the review period, advances in technology and improved systems will drive growth in the Tay-Sachs Disease Market industry. Get…

Continue Reading Latest Innovations, Drivers and Industry Key Events 2021-2027 I Top key players-Recursion Pharmaceuticals, Inc, IntraBio Inc, Johnson & Johnson Services,& Others. – The Manomet Current